As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

Floating Genes

Pépinière Genopole Entreprises
4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – France

Dipanwita BISWAS: CSO
Floating Genes - entreprises génopolitaines Floating Genes - entreprises génopolitaines

Shaker#Diagnostics #Medical devices

  • Oncology
  • BoosterIn vitro diagnosis
  • Liquid biopsy
  • Genetics


Field of Activity

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

In 2020, Dr. Dipanwita Biswas conceptualized a method to detect rare mutations in liquid biopsies, validated it in Genopole’s Shaker program and, in October 2021, founded Floating Genes.

Description of the Products / Services / Technology
The start-up is developing tools for the early detection of cancer in liquid biopsies. The initial approach comprises two principal components: a kit with “Enhance-seq” technology reagents, and a computer program to analyze next-generation sequencing data.

Customer references / Partnerships / Highlights
The project was chosen for Genopole’s Shaker program where its proof of concept was achieved. The project demonstrated its feasibility in a synthetic system. A Wilco and Réseau Entreprendre laureate, Floating Genes was selected then accredited by the Cancer Campus’s OncoEntrepreneur program at the OncoSTART and IFODS conference and by the EIT Health WildCard program.

Partnerships Sought
Floating Genes is looking for scientific and clinical partnerships with, e.g., hospitals and biobanks (liquid biopsy samples) and experts in genetics and microfluidics.


  • More information

    1 patent

    2 staff members

    Ultra-sensitive technology for the detection of rare mutations.

    A low sequencing depth is sufficient for the technology.

Genopole’s Companies


In the same field

CGenetix - Entreprise génopolitaine


CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

EndoGene.Bio - Genopole's Company


Research & development for an in vitro diagnostic tool for endometriosis

SafeInsight - Entreprise génopolitaine


SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Innovhem - Entreprise génopolitaine


Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

IntegraGen - Genopole's Company


IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Enalees - Genopole Company 2024


Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

View all >
With the support from
Région île de France